Wuhan Xiangfang Clinical Pharmacology Research Center

Wuhan Xiangfang Clinical Pharmacology Research Center is a specialized Contract Research Organization (CRO) located in Wuhan, China, focusing on clinical pharmacology and bioequivalence (BE) studies. The center provides a full suite of services for Phase I-IV clinical trials, including protocol design, site management, data management, and statistical analysis. It is particularly recognized for its expertise in early-phase clinical research and pharmacokinetic/pharmacodynamic (PK/PD) evaluations. Operating under strict Good Clinical Practice (GCP) guidelines, the organization supports both domestic and international pharmaceutical clients in navigating the regulatory landscape for drug approval. Its strategic location within the Wuhan National Bio-industry Base (Biolake) allows for close collaboration with leading medical institutions and researchers.